POC Hematology Diagnostics Market Demand, Share & Growth by 2034

POC Hematology Diagnostics Market Size and Forecasts (2021–2034), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage : by Product (Systems, Consumables); and Geography (North America, Europe, Asia Pacific, and South and Central America)

Historic Data: 2021-2024 | Base Year: 2025 | Forecast Period: 2026-2034
  • Status : Data Released
  • Report Code : TIPRE00040757
  • Category : Life Sciences
  • No. of Pages : 150
  • Available Report Formats : pdf-format excel-format
  • Last update date : May 26, 2026
POC Hematology Diagnostics Market Demand, Share & Growth by 2034
Report Date: May 26, 2026   |   Report Code: TIPRE00040757 Email: sales@theinsightpartners.com

2025 Market Size

US$ 2.75 Bn

Base year value

2034 Forecast

US$ 4.35 Bn

Projected by 2034

CAGR 2026-2034

5.90 %

Growth rate

Addressable Market

US$ 33.33 Bn

(2026-2034)

The POC Hematology Diagnostics Market size is expected to reach US$ 4.35 Billion by 2034 from US$ 2.75 Billion in 2025. The market is estimated to record a CAGR of 5.90% from 2026 to 2034.

The report is segmented by Product (Systems, Consumables). The global analysis is further broken-down at regional level and major countries. The report offers the value in USD for the above analysis and segments.

Purpose of the Report

The report POC Hematology Diagnostics Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:

  1. Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
  2. Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
  3. Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.

POC Hematology Diagnostics Market Segmentation Product

  1. Systems
  2. Consumables

Market Research Highlights

  • Global market for POC Hematology Diagnostics was valued at US$ 2.75 Billion in 2025
  • Annual market size is expected to reach US$ 4.35 Billion by 2034
  • Total addressable market (TAM) during 2026-2034 is projected to reach approximately US$ 33.33 Billion
  • Market is anticipated to register a CAGR of 5.9% during the forecast period
  • The United States represents a key market, supported by Rising Incidence of Blood Disorders, Growing Demand for Home Healthcare, Cost Efficiency and Time Savings, as well as evolving industry dynamics
  • Market analysis covers North America, Europe, Asia-Pacific, South and Central America, Middle East and Africa, with growth evaluated across the forecast period
  • Market opportunities such as Partnerships with Hospitals and Clinics, Development of Multi-parameter Testing Devices, Increasing Focus on Preventive Healthcare are expected to influence market dynamics and addressable market
  • Report profiles industry participants, including Abbott, Madison Medical Diagnostics LLC, Sysmex Corporation, EKF Diagnostics, Danaher Corporation, Siemens Healthineers, PixCell Medical Technologies Ltd, F. Hoffman-La Roche Ltd, Thermo Fisher Scientific, Bio-Rad Laboratories, while analyzing competitive strategies and innovation developments
  • Source: The Insight Partners' analysis based on proprietary research, government publications, company annual reports, investor presentations, industry databases, and expert interviews.

● REPORT CUSTOMIZATION

Tailor This Report To Align With Your Specific Business Requirements

This report can be customized to align precisely with your business objectives, scope, and target markets. Customization options include tailored segmentation, geography, competitive analysis, and strategic insights to support informed decision-making.

Customize This Report →

WHAT YOU CAN ADJUST

  • Segmentations
  • Geography
  • Competitive Analysis
  • Language Preferences

POC Hematology Diagnostics Market: Strategic Insights

poc-hematology-diagnostics-market
  • Get Top Key Market Trends of this report.
    This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

POC Hematology Diagnostics Market Growth Drivers

  1. Rising Incidence of Blood Disorders: The increasing prevalence of blood disorders like anemia, leukemia, and thrombocytopenia has fueled demand for rapid and reliable diagnostic tools. Early detection is critical, and POC devices offer immediate results that allow for faster intervention.
  2. Growing Demand for Home Healthcare: With the shift towards decentralized care, there is a growing need for home-based diagnostic tools. POC hematology devices enable patients to perform tests at home, reducing the need for hospital visits and improving patient compliance with treatment regimens.
  3. Cost Efficiency and Time Savings: Traditional lab testing can be costly and time-consuming, whereas POC hematology diagnostics offer a cost-effective solution by providing quicker, on-site results. This reduces patient wait times, minimizes healthcare system burden, and improves overall cost efficiency.

POC Hematology Diagnostics Market Future Trends

  1. Integration of AI and Machine Learning: The incorporation of artificial intelligence and machine learning into POC hematology devices is expected to drive automation and enhance diagnostic accuracy. These technologies will assist in better interpreting results and predicting patient outcomes, thus improving overall care.
  2. Personalized Medicine: The rise of personalized medicine will require more tailored and precise diagnostic tools. POC hematology devices will evolve to offer tests that can help in individualizing treatment plans, especially for chronic conditions and complex hematological diseases.
  3. Telemedicine Integration: The convergence of POC testing with telemedicine platforms will allow for remote monitoring of blood health. This will enable healthcare providers to remotely track patient conditions, adjust treatment plans in real time, and offer more efficient care management.

POC Hematology Diagnostics Market Opportunities

  1. Partnerships with Hospitals and Clinics: Collaborating with hospitals and clinics to integrate POC hematology diagnostic devices into their existing infrastructures presents a great opportunity. These collaborations can enhance the availability and adoption of advanced diagnostic tools in clinical settings, improving patient outcomes.
  2. Development of Multi-parameter Testing Devices: There is growing potential in developing devices that can perform multiple hematology tests simultaneously. These multi-parameter devices can offer broader diagnostic capabilities and improve convenience, especially for patients with complex health conditions requiring multiple tests.
  3. Increasing Focus on Preventive Healthcare: As healthcare moves towards prevention rather than treatment, POC hematology devices can be leveraged for routine screening. Regular blood tests can help in the early detection of abnormalities, creating opportunities for companies that provide preventive diagnostic solutions.

POC Hematology Diagnostics Market Report Scope

Report Attribute Details
Market size in 2025 US$ 2.75 Billion
Market Size by 2034 US$ 4.35 Billion
Global CAGR (2026 - 2034) 5.90%
Historical Data 2021-2024
Forecast period 2026-2034
Segments Covered By Product
  • Systems
  • Consumables
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Abbott
  • Madison Medical Diagnostics LLC
  • Sysmex Corporation
  • EKF Diagnostics
  • Danaher Corporation
  • Siemens Healthineers
  • PixCell Medical Technologies Ltd
  • F. Hoffman-La Roche Ltd
  • Thermo Fisher Scientific
  • Bio-Rad Laboratories

POC Hematology Diagnostics Market Players Density: Understanding Its Impact on Business Dynamics

The POC Hematology Diagnostics Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

poc-hematology-diagnostics-market-cagr

Key Selling Points

  1. Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the POC Hematology Diagnostics Market, providing a holistic landscape.
  2. Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
  3. Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
  4. Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.

The research report on the POC Hematology Diagnostics Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.


Frequently Asked Questions

The POC hematology diagnostics market is estimated to witness a CAGR of 5.90% from 2026 to 2034

The major factors driving the POC hematology diagnostics market are:

1. Rising Incidence of Blood Disorders.

2. Growing Demand for Home Healthcare.

North America region dominated the POC hematology diagnostics market in 2025.

Asia Pacific region accounted for the highest CAGR of 5.90% from 2026 to 2034

The report provides an extensive qualitative and quantitative analysis of the current trends and future estimations of the global POC hematology diagnostics market from 2021 to 2034, and it also determines the prevailing opportunities.

Abbott and Sysmex Corporation are some of the major players operating in the market.
Mrinal Kerhalkar
Manager,
Market Research & Consulting

Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

  • Comprehensive Market Sizing and Forecast Analysis
  • Detailed Segmentation Analysis
  • In-Depth Market Dynamics Assessment
  • Regional and Country-Level Insights
  • Competitive Landscape and Company Benchmarking
  • Strategic Business Intelligence

Testimonials

Reason to Buy

  • Informed Decision-Making
  • Understanding Market Dynamics
  • Competitive Analysis
  • Identifying Emerging Markets
  • Customer Insights
  • Market Forecasts
  • Risk Mitigation
  • Boosting Operational Efficiency
  • Strategic Planning
  • Investment Justification
  • Tracking Industry Innovations
  • Aligning with Regulatory Trends
Sales Assistance
US: +1-646-491-9876
UK: +44-20-8125-4005
DUNS Logo
ISO Certified Logo
GDPR
CCPA